International Clinical Project Manager

SIOPEN brings together clinicians and other specialists from more than 20 countries in Europe and across the world to improve the outcomes for patients with neuroblastoma. International collaboration is vital for both clinical and translational research to improve treatment for children with neuroblastoma. SIOPEN runs a number of large clinical trials. In addition, it leads research in the fields of pathology, biology, immunology and others to provide a better understanding of neuroblastoma oncogenesis. Specialty Committees within SIOPEN focus on specific areas such as biology, pathology, immunology, molecular monitoring of response, imaging techniques, and surgery.

Based on existing structures, SIOPEN is now developing the SIOPEN BIOPORTAL, An International Registry Linked to a Virtual Biobank for patients with peripheral neuroblastic tumours.

The SIOPEN BIOPORTAL is a prospective non-therapeutic multi-centre international study aimed at developing an international Registry linked to a Virtual Biobank for all the patients with peripheral neuroblastic tumor within countries of the SIOPEN network. The overall aim of this study is to provide a GDPR-compliant framework to collect basic clinical annotations, biological and genetic features and information about the location on biospecimens for all the patients with a peripheral neuroblastic tumor including neuroblastoma, ganglioneuroblastoma and ganglioneuroma in the SIOPEN network.
This study will support data and sample management and intensify collaborative data and sample sharing fostering translational and clinical research. The post-hoc hypothesis formulated based on the data generated in this study will be used as statistical basis for future precision medicine programs based on improved biological characterization, patient stratification and therapeutic management. Importantly this resource is the bases for international scientific clinic-biological research aiming to improve treatment for patients with neuroblastoma.

To know more: https://www.siopen.net/

POSITION
Based at Institut Curie (Paris and Saint-Cloud, France), a full-time position of International Clinical Project Manager for a period of 36 months is now proposed. This position will have a hierarchical link with Dr Gudrun Schleiermacher (pediatric oncologist), as well as close functional links and interactions with the Direction of Research of the Hospital, Institut Curie.

Principal Mission:
Responsible for the national and international management of the SIOPEN BIOPORTAL.

Activities:

• Manage the administrative, regulatory and logistical aspects of the SIOPEN BIOPORTAL in accordance with the current regulations and the scientific objectives of the clinical protocol. Manage the International Consortium Agreement of the SIOPEN BIOPORTAL.
• Coordinate the opening and advancement of the study (administrative, regulatory, contractual, financial aspects, progress reports, etc.) in collaboration with the main actors at the national level (Principal Investigator: Dr Schleiermacher Gudrun), and at the international level (SIOPEN president: Dr Lucas Moreno), in collaboration with the different SIOPEN committees, in compliance with Good Clinical Practices and in accordance with applicable regulations.
• Coordinate the integration of clinico-biological research projects in the SIOPEN BIOPORTAL environment; establish the use of the SIOPEN BIOPORTAL for international collaborative clinico-biological research (for instance the Horizon Cancer Mission/ European-funded MONALISA project)

Secondary missions:

• Support for the management of projects linked to SIOPEN translational research activities
• Support for the identification of funding opportunities and national and international grant applications.

PROFILE

• Level PhD degree or equivalent
• Basic knowledge in pediatric oncology
• Knowledge in tumor biology
• Basic experience in data management would be an advantage
• Clinical research/GCP certification or diploma
• Excellent knowledge of written/spoken English